Show simple item record

dc.contributor.authorBrewer, Carole
dc.date.accessioned2020-01-03T15:07:28Z
dc.date.available2020-01-03T15:07:28Z
dc.date.issued2020-01
dc.identifier.citationNyberg T [et al]. Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort study. European Urology. 2020 Jan;77(1):24-35en_US
dc.identifier.pmid31495749
dc.identifier.doi10.1016/j.eururo.2019.08.025
dc.identifier.urihttps://rde.dspace-express.com/handle/11287/621166
dc.description.abstractBRCA1 and BRCA2 mutations have been associated with prostate cancer (PCa) risk but a wide range of risk estimates have been reported that are based on retrospective studies.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0302-2838(19)30675-Xen_US
dc.rightsThis is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)en_US
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.en_US
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen_US
dc.titleProstate cancer risks for male BRCA1 and BRCA2 mutation carriers: a prospective cohort studyen_US
dc.typeJournal Articleen_US
dc.identifier.journalEuropean Urologyen_US
dc.identifier.pmcidPMC6926480
dc.description.noteThis article is freely available via Open Access. Click on the Publisher URL to access the full-text via the publisher's site.en_US
dc.type.versionPublisheden_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record